Compound in the herb rosemary may be useful against COVID-19 and other inflammatory diseases
- Details
- Category: Research
The scientists, in experiments described in a paper published January 6, 2022 in the journal Antioxidants, found that the compound, carnosic acid, can block the interaction between the SARS-CoV-2 outer "spike" protein and the receptor protein, ACE2, which the virus uses to gain entry to cells.
Current COVID-19 vaccines induce robust cellular immunity against Omicron variant
- Details
- Category: Research
Parental vaccination against coronavirus offers substantial protection to children as well
- Details
- Category: Research
Delta variant, waning immunity reduced Pfizer vaccine's effectiveness against household transmission
- Details
- Category: Research
New study suggests two paths toward ‘super immunity’ to COVID-19
- Details
- Category: Research
A new study finds that two forms of immunity - breakthrough infections following vaccination or natural infection followed by vaccination - provide roughly equal levels of enhanced immune protection.
The cellular response that protects pigs from COVID-19
- Details
- Category: Research
Studies since the start of the pandemic have noted that pigs can be infected by the virus if exposed to high doses, but the infection is self-limited and pigs don’t show clinical signs of disease nor do they transmit the virus to other animals.
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
- Details
- Category: Research
The analysis of 204 countries and territories, published in The Lancet, reveals that AMR is now a leading cause of death worldwide, higher than HIV/AIDS or malaria.
More Pharma News ...
- Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events
- WHO recommends two new drugs to treat patients with COVID-19
- Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19
- COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
- COVID-19 can trigger self-attacking antibodies
- Treatments in weeks, not months: Scientists develop ambitious pandemic response plan
- Scientists identify antibodies that can neutralize omicron